H. Xu et al., Endothelin-1-induced elevation in blood pressure is independent of increases in sympathetic nerve activity in normotensive rats, J CARDIO PH, 38(5), 2001, pp. 784-795
Citations number
29
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
This study was performed to determine if endothelin-1 (ET-I)induced pressor
responses in urethane-anesthetized, normotensive rats are due to increased
sympathetic nerve activity. Renal sympathetic nerve activity (RSNA) was us
ed as an index of sympathetic nerve activity. ET-1 (30-1000 pmol/kg) or sar
afotoxin (S6c, ETB receptor agonist, 10-3,000 nmol/kg) given by bolus injec
tion produced transient decreases in mean arterial pressure (MAP) and incre
ases in RSNA and heart rate (HR). ET-1 caused a delayed but sustained incre
ase in MAP that was not inhibited by acute sinoaortic denervation or alpha
(1)-adrenergic receptor blockade. ET-1 never caused a sustained change in H
R or RSNA. A-192621 (ETB receptor antagonist, 12 mg/kg) increased MAP (10-2
0 mm Hg) and decreased HR and RSNA. A-192621 blocked the transient decrease
in MAP and increase in RSNA and HR caused by ET-1 and S6c. In A-192621-tre
ated rats, ET-1, but not S6c, caused a sustained increase in MAP and decrea
se in HR and RSNA. After A-192621 treatment, ET-I infusion caused a sustain
ed elevation in MAP; HR and RSNA decreased only after the highest ET-1 dose
. These results indicate that the initial increase in RSNA after ET-1 or S6
c is secondary to ETB receptor-mediated vasodilation. Increased RSNA does n
ot contribute to ET-1-induced pressor responses; these responses are likely
due to vasoconstriction in normotensive, anesthetized rats. Finally, baror
eceptor reflexes function after ET-1 or S6c treatment.